Head-to-head
NexLife vs LillyDirect (Zepbound)
Compared on tirzepatide across the eight dimensions this database records. They differ on 6 of those eight. NexLife is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
NexLife is $129 a month all-in for tirzepatide; LillyDirect (Zepbound) is $449. Over twelve months that is $1,380 against $5,388. Value Scores are 96.1 and 39.6 out of 100.
Tirzepatide
Plan pages: NexLife plans · LillyDirect (Zepbound) plans
At 10 mg/week, NexLife is $129 a month all-in and LillyDirect (Zepbound) is $449 — $320 apart, or $3,840 across a year. Over twelve months the totals are $1,380 (12-month plan) and $5,388 (billed monthly).
NexLife charges a flat $129 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
LillyDirect (Zepbound) prices tirzepatide by dose: $299 per month at 2.5 mg rising to $449 at 7.5 mg, a difference of $150 a month between the bottom and top of the ladder.
| Dose | NexLife | LillyDirect (Zepbound) | Cheaper |
|---|---|---|---|
| 2.5 mg | $129 | $299 | NexLife by $170 |
| 5 mg | $129 | $399 | NexLife by $270 |
| 7.5 mg | $129 | $449 | NexLife by $320 |
| 10 mg | $129 | $449 | NexLife by $320 |
| 12.5 mg | $129 | $449 | NexLife by $320 |
| 15 mg | $129 | $449 | NexLife by $320 |
NexLife is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, the field median is $299 a month all-in. NexLife, at $129, is $170 below it; LillyDirect (Zepbound), at $449, is $150 above it.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide price in this database, is $449 a month at 10 mg/week — NexLife is $320 below it. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | NexLife | LillyDirect (Zepbound) | Cheaper |
|---|---|---|---|
| Month to month | $129 | $449 | NexLife by $320 |
| 3-month term | $125 | — | only NexLife publishes this term |
| 6-month term | $119 | — | only NexLife publishes this term |
| 12-month term | $115 | — | only NexLife publishes this term |
| Settled dose | NexLife | LillyDirect (Zepbound) | Difference |
|---|---|---|---|
| 2.5 mg | $1,548 | $3,588 | $2,040 apart |
| 5 mg | $1,548 | $4,788 | $3,240 apart |
| 7.5 mg | $1,548 | $5,388 | $3,840 apart |
| 10 mg | $1,548 | $5,388 | $3,840 apart |
| 12.5 mg | $1,548 | $5,388 | $3,840 apart |
| 15 mg | $1,548 | $5,388 | $3,840 apart |
LillyDirect (Zepbound) publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $1,548 on NexLife and $5,188 on LillyDirect (Zepbound) — $3,640 apart, and a different gap from the $3,840 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
Value Scores are 96.1 for NexLife and 39.6 for LillyDirect (Zepbound), against a tirzepatide category floor of $126. NexLife leads by 56.5 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| NexLife | 68.4 | 12.8 | 10 | 5 | 96.1 |
| LillyDirect (Zepbound) | 19.6 | 15.0 | 0 | 5 | 39.6 |
Where the two programs differ
All-in monthly
NexLife is cheaper month to month — $129 against $449, a gap of $320 every month, or $3,840 across a year if both rates hold.
Cancellation terms
Cancellation differs: NexLife states Cancellations take effect after 30 days, so one additional shipment may be charged (plan pages), while LillyDirect (Zepbound) states No subscription lock. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
NexLife asks for None on month to month; 3-, 6- and 12-month plans start only if prescribed, and unshipped months are refunded if treatment stops; LillyDirect (Zepbound) asks for None; Journey Program pricing requires refill within 45 days on 7.5 mg+. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
NexLife charges one price at every dose; LillyDirect (Zepbound) prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. NexLife's figure is provider-stated and LillyDirect (Zepbound)'s is verified. LillyDirect (Zepbound) rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $1,380 for NexLife and $5,388 for LillyDirect (Zepbound). NexLife is lower by $4,008 — a figure worth checking against the cancellation terms below, because a longer plan is only cheaper if you stay on it.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
NexLife Official site
NexLife sells compounded tirzepatide and semaglutide at one price at every dose, with no membership fee. The price includes provider review and medical guidance (NexLife Medical Group), a personalized GLP-1 nutrition plan, a 1:1 call with a certified wellness coach, 24/7 support and free expedited shipping. Labs are not listed as included.
It names its compounding pharmacy — Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL), Boudreaux's New Drug Store (Lake Charles, LA), recorded as State-licensed 503A compounding pharmacies (named on plan pages) — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None on month to month; 3-, 6- and 12-month plans start only if prescribed, and unshipped months are refunded if treatment stops; cancellation is Cancellations take effect after 30 days, so one additional shipment may be charged (plan pages); availability is stated as All 50 US states where affiliated providers are licensed.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — nexlife.us plan pages, read 2026-11-06
Watch: Plans continue monthly unless canceled, and a cancellation takes effect after 30 days, so one more shipment may be charged. NexLife's refund policy page covers program fees, not medication, for members who lose less than 5% of starting weight over 180 days, with conditions. Provider-stated from nexlife.us plan pages read November 6, 2026; checkout capture pending.
LillyDirect (Zepbound) Official site
The manufacturer's own cash channel for FDA-approved Zepbound (KwikPen or vial): $299/month at 2.5 mg, $399 at 5 mg, and $449 for every dose from 7.5 to 15 mg through the self-pay program, provided each refill lands within 45 days of the last; otherwise a refill costs $499 at 7.5 mg and $699 at 10 to 15 mg. The savings card allows up to 11 fills a calendar year and its savings end December 31, 2026. It is the lowest FDA-approved tirzepatide price in this database and the benchmark every compounded price should be judged against.
It names its compounding pharmacy — Eli Lilly self-pay pharmacy (GiftHealth), recorded as Manufacturer direct — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None; Journey Program pricing requires refill within 45 days on 7.5 mg+; cancellation is No subscription lock; availability is stated as 50 states.
Evidence: verified — captured at checkout by our desk on the stated date, captured . Source — Lilly investor announcement Dec 1, 2025 + LillyDirect program pages; corroborated by drugs.com pricing review updated Jun 12, 2026
Watch: The 45-day refill window is the whole game: one late refill at 10 mg costs $699 instead of $449. The current self-pay terms end December 31, 2026.
Which molecules each one carries
NexLife carries tirzepatide at $129 a month and semaglutide at $109 a month.
LillyDirect (Zepbound) carries tirzepatide at $449 a month; does not offer semaglutide.
Comparable only on tirzepatide: they do not both publish a rankable semaglutide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
NexLife does not publish
- no state-by-state availability list — it says All 50 US states where affiliated providers are licensed
LillyDirect (Zepbound) does not publish
- no published twelve-month tirzepatide rate
Ask NexLife and LillyDirect (Zepbound) for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. NexLife carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Plan length moves the annual figures. NexLife publishes a twelve-month rate of $115 a month against $129 month to month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lower standing monthly rate for tirzepatide, NexLife Official site wins this matchup. If you expect to titrate to the top of the ladder, nexlife's flat pricing is worth more than the headline gap suggests; and if you would rather trust a better-evidenced number, lillydirect (zepbound)'s price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. NexLife's tirzepatide price is provider-stated as of 2026-11-06; LillyDirect (Zepbound)'s is verified as of 2026-08-11.
Questions
Is NexLife or LillyDirect (Zepbound) cheaper for tirzepatide?
NexLife is cheaper on all-in monthly cost at 10 mg/week: $129 against $449, a difference of $320 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of NexLife versus LillyDirect (Zepbound)?
NexLife works out to $1,380 across twelve months and LillyDirect (Zepbound) to $5,388, on the plan terms each publishes.
Does NexLife or LillyDirect (Zepbound) raise the price as the dose goes up?
NexLife: no, it charges one flat rate at every dose. LillyDirect (Zepbound): yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do NexLife and LillyDirect (Zepbound) differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of NexLife and LillyDirect (Zepbound) names its pharmacy?
Both do. NexLife names Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL), Boudreaux's New Drug Store (Lake Charles, LA) and LillyDirect (Zepbound) names Eli Lilly self-pay pharmacy (GiftHealth), so both can be checked against state board licensing and FDA inspection records.
How well evidenced are the NexLife and LillyDirect (Zepbound) prices?
NexLife's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-11-06. LillyDirect (Zepbound)'s is verified, captured 2026-08-11. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: NexLife official site · LillyDirect (Zepbound) official site. Compounded tirzepatide and semaglutide are not FDA-approved products.